Moloney Sarcoma Oncogene (MOS) (Middle Region) Peptide
Quick Overview for Moloney Sarcoma Oncogene (MOS) (Middle Region) Peptide (ABIN980193)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MOS antibody (Catalog #: ARP56631_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MOS (Moloney Sarcoma Oncogene (MOS))
-
Background
-
MOS is a serine/threonine kinase that activates the MAP kinase cascade through direct phosphorylation of the MAP kinase activator MEK (MAP2K1, MIM 176872) (Prasad et al., 2008 [PubMed 18246541]).
Alias Symbols: MGC119962, MGC119963, MSV
Protein Interaction Partner: BMPR2,HSPA1A,MYOD1,MYOD1
Protein Size: 346 -
Molecular Weight
- 38 kDa
-
Gene ID
- 4342
-
NCBI Accession
- NM_005372, NP_005363
-
UniProt
- P00540
Target
-